Earlier clinical research of CagriSema found that it served sufferers realize drastically greater weight loss than semaglutide (Wegovy) did. even when Lilly's Zepbound/Mounjaro topples Wegovy, it's feasible that CagriSema could enter the marketplace at the best time for Novo Nordisk to retain its Total leadership within the weight problems drug mar… Read More